as of 6/30/01 FORM 13F
(SEC USE ONLY)
Page of Name of Reporting Manager: HAMBRECHT & QUIST CAPITAL MANAGEMENT
------------------------------------------------------------------------------------------------------------------------------------
Item 5: Item 6:
Item 1: Item 2: Item 3: Item 4: Shares of Investment Discretion
Name of Issuer Title of Class CUSIP Fair Market Principal (b) Shared-
Number Value Amount (a) Sole As Defined (c) Shared-
in Instr. V Other
------------------------------------------------------------------------------------------------------------------------------------
Affymetrix Common 00826T108 2,205,000 100,000 X
Aradigm Common 038505103 2,450,000 350,000 X
ATS Medical Common 002083103 9,583,642 636,364 X
Biofield Common 090591207 316,356 878,766 X
Biofield (Restricted) Common 090591207 288,000 1,000,000 X
Bioject Medical Technologies Common 09059T206 2,810,780 238,000 X
Biopure Common 09065H915 4,476,202 169,746 X
BioTransplant Common 09066Y107 5,522,015 712,518 X
Biovail Common 09067K106 24,853,638 571,348 X
Calypte Biomedical Common 131722100 459,477 1,093,993 X
Catalytica Energy Systems Common 148884109 2,788,775 128,515 X
Celgene Common 151020104 19,906,500 690,000 X
Cor Therapeutics Common 217753102 9,150,000 300,000 X
Corixa Common 21887F100 6,682,222 391,460 X
Cubist Pharmaceuticals Common 229990981 36,404,190 958,005 X
Curis Common 231269101 2,149,710 340,684 X
CV Therapeutics Common 126667104 31,139,499 546,307 X
Cytyc Common 232946103 10,010,293 434,286 X
Digene Common 253752109 9,384,000 230,000 X
Dyax Common 26746E103 10,388,535 546,765 X
Emisphere Technologies Common 291345106 4,389,570 151,000 X
Endocardial Solutions (Restricted) Common 292962107 9,583,330 1,666,666 X
Envirogen Common 294040100 22,812 20,833 X
EP Med Systems Common 26881P103 2,795,000 1,075,000 X
Exelixis Common 30161Q104 4,249,280 224,000 X
Focal Common 343909107 331,812 271,977 X
Genzyme Common 372917104 16,419,000 269,000 X
Genzyme Biosurgery Common 372917708 955,574 115,547 X
Gilead Sciences Common 37555B103 41,507,974 713,318 X
IDEXX Laboratories Common 45168D104 7,812,500 250,000 X
ImClone Systems Common 45245W109 4,488,000 85,000 X
KeraVision Common 648990992 6,186 206,185 X
Lynx Therapeutics Common 551812308 2,565,000 375,000 X
Martek Biosciences Common 572901106 22,236,385 780,224 X
MedImmune Common 584699102 15,576,000 330,000 X
Molecular Devices Common 60851C107 5,829,898 290,768 X
Orthovita (Restricted) Common 68750U102 5,936,400 1,700,000 X
Quintiles Transnational Common 748767100 3,860,725 152,900 X
Radiance Medical Systems Common 750241101 1,742,400 330,000 X
Scios Common 808905103 13,943,075 557,500 X
Sepracor Common 817315104 14,214,092 357,138 X
Telik Common 87959M109 6,566,650 666,665 X
Teva Pharmaceutical Industries Common 881624209 6,230,000 100,000 X
Transkaryotic Therapies Common 893735100 11,266,097 382,550 X
Tularik Common 899165104 10,471,611 405,405 X
Verdant Brands Common 923366108 228 38,000 X
Versicor Common 925314106 9,405,000 750,000 X
Versicor (Restricted) Common 925314106 2,792,730 296,941 X
COLUMN TOTALS 416,166,163
(SEC USE ONLY)
Page of Name of Reporting Manager: HAMBRECHT & QUIST CAPITAL MANAGEMENT
-----------------------------------------------------------------------------------------------------
Item 8:
Item 1: Item 7: Voting Authority (Shares)
Name of Issuer Managers
See Instr. V (a) Sole (b) Shared (c) None
------------------------------------------------------------------------------------------------------
Affymetrix NA X
Aradigm NA X
ATS Medical NA X
Biofield NA X
Biofield (Restricted) NA X
Bioject Medical Technologies NA X
Biopure NA X
BioTransplant NA X
Biovail NA X
Calypte Biomedical NA X
Catalytica Energy Systems NA X
Celgene NA X
Cor Therapeutics NA X
Corixa NA X
Cubist Pharmaceuticals NA X
Curis NA X
CV Therapeutics NA X
Cytyc NA X
Digene NA X
Dyax NA X
Emisphere Technologies NA X
Endocardial Solutions (Restricted) NA X
Envirogen NA X
EP Med Systems NA X
Exelixis NA X
Focal NA X
Genzyme NA X
Genzyme Biosurgery NA X
Gilead Sciences NA X
IDEXX Laboratories NA X
ImClone Systems NA X
KeraVision NA X
Lynx Therapeutics NA X
Martek Biosciences NA X
MedImmune NA X
Molecular Devices NA X
Orthovita (Restricted) NA X
Quintiles Transnational NA X
Radiance Medical Systems NA X
Scios NA X
Sepracor NA X
Telik NA X
Teva Pharmaceutical Industries NA X
Transkaryotic Therapies NA X
Tularik NA X
Verdant Brands NA X
Versicor NA X
Versicor (Restricted) NA X
COLUMN TOTALS